|
1
|
Phillips IR and Shephard EA: Drug
metabolism by flavin-containing monooxygenases of human and mouse.
Expert Opin Drug Metab Toxicol. 13:167–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Phillips IR and Shephard EA:
Flavin-containing monooxygenase 3 (FMO3): Genetic variants and
their consequences for drug metabolism and disease. Xenobiotica.
50:19–33. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu M, Bhatt DK, Yeung CK, Claw KG,
Chaudhry AS, Gaedigk A, Pearce RE, Broeckel U, Gaedigk R, Nickerson
DA, et al: Genetic and nongenetic factors associated with protein
abundance of flavin-containing monooxygenase 3 in human liver. J
Pharmacol Exp Ther. 363:265–274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang YJ, Hu K, Huang WH, Wang CZ, Liu Z,
Chen Y, Ouyang DS, Tan ZR, Zhou HH and Yuan CS: Effects of FMO3
polymorphisms on pharmacokinetics of sulindac in Chinese healthy
male volunteers. BioMed Res Int. 2017:41896782017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ceriello A, De Nigris V, Iijima H, Matsui
T and Gouda M: The unique pharmacological and pharmacokinetic
profile of teneligliptin: Implications for clinical practice.
Drugs. 79:733–750. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park JW, Kim KA, Kim JM, Park IH and Park
JY: Influence of FMO3 and CYP3A4 polymorphisms on the
pharmacokinetics of teneligliptin in humans. Front Pharmacol.
12:7363172021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei H, Zhao M, Huang M, Li C, Gao J, Yu T,
Zhang Q, Shen X, Ji L, Ni L, et al: FMO3-TMAO axis modulates the
clinical outcome in chronic heart-failure patients with reduced
ejection fraction: evidence from an Asian population. Front Med.
Jun 22–2021.(Epub ahead of print). doi: 10.1007/s11684-021-0857-2.
View Article : Google Scholar
|
|
8
|
Scimone C, Alibrandi S, Donato L, Giofrè
SV, Rao G, Sidoti A and D'Angelo R: Antiretroviral treatment
leading to secondary trimethylaminuria: Genetic associations and
successful management with riboflavin. J Clin Pharm Ther.
46:304–309. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimizu M, Allerston CK, Shephard EA,
Yamazaki H and Phillips IR: Relationships between flavin-containing
mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in
a Japanese population. Br J Clin Pharmacol. 77:839–851. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimizu M, Kobayashi Y, Hayashi S, Aoki Y
and Yamazaki H: Variants in the flavin-containing monooxygenase 3
(FMO3) gene responsible for trimethylaminuria in a Japanese
population. Mol Genet Metab. 107:330–334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimizu M, Yoda H, Igarashi N, Makino M,
Tokuyama E and Yamazaki H: Novel variants and haplotypes of human
flavin-containing monooxygenase 3 gene associated with Japanese
subjects suffering from trimethylaminuria. Xenobiotica.
49:1244–1250. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shimizu M, Yoda H, Nakakuki K, Saso A,
Saito I, Hishinuma E, Saito S, Hiratsuka M and Yamazaki H: Genetic
variants of flavin-containing monooxygenase 3 (FMO3) derived from
Japanese subjects with the trimethylaminuria phenotype and
whole-genome sequence data from a large Japanese database. Drug
Metab Pharmacokinet. 34:334–339. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park S, Lee NR, Lee KE, Park JY, Kim YJ
and Gwak HS: Effects of single-nucleotide polymorphisms of FMO3 and
FMO6 genes on pharmacokinetic characteristics of sulindac sulfide
in premature labor. Drug Metab Dispos. 42:40–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sung JW, Yun HY, Park S, Kim YJ, Yee J,
Lee KE, Song B, Chung JE and Gwak HS: Population pharmacokinetics
of sulindac and genetic polymorphisms of FMO3 and AOX1 in women
with preterm labor. Pharm Res. 37:442020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kwak HD, Kim SH, Seo YS and Song KJ:
Detecting hepatitis B virus in surgical smoke emitted during
laparoscopic surgery. Occup Environ Med. 73:857–863.
2016.PubMed/NCBI
|
|
16
|
Abramovs N, Brass A and Tassabehji M:
Hardy-weinberg equilibrium in the large scale genomic sequencing
era. Front Genet. 11:2102020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du FX, Clutter AC and Lohuis MM:
Characterizing linkage disequilibrium in pig populations. Int J
Biol Sci. 3:166–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sunderaraman P, Cosentino S, Schupf N,
Manly J, Gu Y and Barral S: MEF2C common genetic variation is
associated with different aspects of cognition in non-hispanic
white and caribbean hispanic non-demented older adults. Front
Genet. 12:6423272021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimizu M, Mizugaki A, Koibuchi N, Sango
H, Uenuma Y and Yamazaki H: A series of simple detection systems
for genetic variants of flavin-containing monooxygenase 3 (FMO3)
with impaired function in Japanese subjects. Drug Metab
Pharmacokinet. 41:1004202021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chuwongwattana S, Jantararoungtong T,
Prommas S, Medhasi S, Puangpetch A and Sukasem C: Impact of
CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole
in Thai patients with invasive fungal infections. Pharmacol Res
Perspect. 8:e006652020. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
D'Angelo R, Scimone C, Esposito T,
Bruschetta D, Rinaldi C, Ruggeri A and Sidoti A: Fish odor syndrome
(trimethylaminuria) supporting the possible FMO3 down expression in
childhood: A case report. J Med Case Reports. 8:3282014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sanger F, Nicklen S and Coulson AR: DNA
sequencing with chain-terminating inhibitors. Proc Natl Acad Sci
USA. 74:5463–5467. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ronaghi M, Uhlén M and Nyrén P: A
sequencing method based on real-time pyrophosphate. Science.
281:363–365. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Siqueira JF Jr..Fouad AF and Rôças IN:
Pyrosequencing as a tool for better understanding of human
microbiomes. J Oral Microbiol. Jan 23–2012.(Epub ahead of print).
doi: 10.3402/jom.v4i0.10743. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Zhao J, Wen T, Liao X and Luo B:
Predictive value of FMO3 variants on plasma disposition and adverse
reactions of oral voriconazole in febrile neutropenia.
Pharmacology. 106:202–210. 2021.PubMed/NCBI
|
|
26
|
Fennema D, Phillips IR and Shephard EA:
Trimethylamine and trimethylamine N-Oxide, a flavin-containing
monooxygenase 3 (FMO3)-mediated host-microbiome metabolic Axis
implicated in health and disease. Drug Metab Dispos. 44:1839–1850.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Weng Z, Liu Q, Shao W, Guo W, Chen
C, Jiao L, Wang Q, Lu Q, Sun H, et al: FMO3 and its metabolite TMAO
contribute to the formation of gallstones. Biochim Biophys Acta Mol
Basis Dis. 1865:2576–2585. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Su C, Jiang Z, Yang Y, Zhang Y, Yang
M, Zhang X, Du Y, Zhang J, Wang L, et al: Berberine attenuates
choline-induced atherosclerosis by inhibiting trimethylamine and
trimethylamine-N-oxide production via manipulating the gut
microbiome. NPJ Biofilms Microbiomes. 7:362021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ren W, Zhou C, Liu Y, Su K, Jia L, Chen L,
Li M, Ma J, Zhou W, Zhang S, et al: Genetic associations of
docetaxel-based chemotherapy-induced myelosuppression in Chinese
Han population. J Clin Pharm Ther. 45:354–364. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He YY, Hasan AME, Zhang Q, Li SQ, Yang JS,
Yan CX, Chen P, Liu Y, Nadeem A and Zhang B: Novel association
between flavin-containing monooxygenase 3 gene polymorphism and
antithyroid drug-induced agranulocytosis in the han population. Ann
Nutr Metab. 74:200–206. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren L, Teng M, Zhang T, Zhang X, Sun B,
Qin S, Zhong L, Peng Z and Fan J: Donors FMO3 polymorphisms affect
tacrolimus elimination in Chinese liver transplant patients.
Pharmacogenomics. 18:265–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chenoweth MJ, Zhu AZX, Sanderson Cox L,
Ahluwalia JS, Benowitz NL and Tyndale RF: Variation in P450
oxidoreductase (POR) A503V and flavin-containing monooxygenase
(FMO)-3 E158K is associated with minor alterations in nicotine
metabolism, but does not alter cigarette consumption. Pharmacogenet
Genomics. 24:172–176. 2014. View Article : Google Scholar : PubMed/NCBI
|
